	Bladder-sparing strategies for non-muscle-invasive bladder cancer after bacillus Calmette-GuÃ©rin failure: a systematic review. BMJ Oncol Soma T, Takemura K, Toide M, Ito M, Koga F. PMID: 41635525 [PubMed]
	Outcome specific optimal systolic blood pressure targets in high risk patients, balancing cardiovascular benefits, renal risks, and cancer prevention: meta-analysis of randomised controlled trials. BMJ Med Zhang Y, Zhang Y, Yang S, Gan X, Huang Y, Zhang Y, Wu Y, Hou FF, Qin X. PMID: 41635416 [PubMed]
	Influence of the azygos venous pathway state on the surgical complexity of patients with renal cell carcinoma and inferior vena cava tumor thrombus: a retrospective, large-sample study from China. BMC Cancer He C, Zhang R, Zhang H, Zhang S, Wang S. PMID: 41634627 [PubMed - as supplied by publisher]
	Diagnostic practice and awareness of SDH- and FH-deficient renal cell carcinoma: results from an Italian Study Group of uropathology (GIUP) survey. Virchows Arch Fanelli GN, Caliò A, Marletta S, Ballotta M, Barella M, Bellezza G, Bianco P, Bonadio AG, Colombo P, D'Amuri A, De Chiara G, Errigo V, Fiorini D, Franzi F, Liscia D, Marcolini L, Onnis D, Pagliuca F, Bonifazi AP, Pierconti F, Pozzi B, Stefanizzi L, Valeri M, Vescovo M, Martignoni G. PMID: 41634405 [PubMed - as supplied by publisher]
	Comparative diagnostic accuracy of multiparametric-MRI and Micro-ultrasound for clinically significant prostate cancer-a bivariate meta-analysis of prospective studies. Prostate Cancer Prostatic Dis Garcia-Becerra CA, Arias-Gallardo MI, Juarez-Garcia JE, Soltero-Molinar V, El Rassi AJ, Rivera-Rocha MI, Parra-Camaño LF, Ruiz M, Garcia-Becerra N, Cordeiro MD, García-Gutiérrez CM. PMID: 41634333 [PubMed - as supplied by publisher]
	Changes in circulating small non-coding RNAs after castration in a cohort of prostate cancer patients. Sci Rep Main AM, Sørensen LH, Winge SB, Fode M, Sønksen J, Juul A, Østergren PB, Mørup N, Almstrup K. PMID: 41634311 [PubMed - as supplied by publisher]
	Robotic versus laparoscopic radical prostatectomy: a large cohort study using the 24-hour pad test highlights the impact of continence definition on functional outcomes. J Robot Surg Domínguez Argomedo R, Collado Serra A, Palop Moscardó A, Arlandis Guzmán S, García Cortés Á, López Gonzalez JA, Wong Gutierrez A, Gutierrez Castañé C, Colombas Vives J, Hernandez Falcón J, Domínguez Escrig JL, Gómez-Ferrer Lozano Á, Beamud Cortés M, Casanova Ramón-Borja JL, de Pablos-Rodríguez P. PMID: 41634271 [PubMed - indexed for MEDLINE]
	Radiographic Progression Without Prostate-specific Antigen Progression in Metastatic Hormone-sensitive Prostate Cancer: A Retrospective Analysis of the ENZAMET Trial (ANZUP 1304). Eur Urol Oncol Inderjeeth AJ, Martin AJ, Zielinski RR, Begbie S, Cheung L, Chowdhury S, Frydenberg M, Horvath LG, Joshua AM, Lawrence NJ, Marx G, McCaffrey J, McDermott RS, McJannett M, North SA, Parnis F, Parulekar WR, Pook DW, Reaume MN, Sandhu S, Tan A, Tan TH, Thomson AH, Vera-Badillo F, Williams SG, Thomas H, Yip S, Zhang AY, Chi KN, Stockler MR, Sweeney CJ, Davis ID, ENZAMET Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group. PMID: 41633909 [PubMed - as supplied by publisher]
	ARCHES 5-year Survival with Enzalutamide Plus Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients. Eur Urol Armstrong AJ, Petrylak DP, Shore ND, Szmulewitz RZ, Holzbeierlein J, Villers A, Alcaraz A, Alekseev B, Iguchi T, Gomez-Veiga F, Croitoru R, Wu R, Kalac M, Tang Y, Stenzl A, Azad AA. PMID: 41633900 [PubMed - as supplied by publisher]
	Bacillus Calmette-GuÃ©rin Plus Mitomycin Versus Bacillus Calmette-GuÃ©rin Alone for Bacillus Calmette-GuÃ©rin-naÃ¯ve Non-muscle-invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301). Eur Urol Hayne D, Zhang AY, Thomas H, Krieger L, Ischia J, Anderson P, Srivastav RK, Green W, Grummet J, Bastick PA, Beardsley EK, Blatt A, Patel M, Chan L, Mitterdorfer A, Roberts M, Sengupta S, Winter M, Marx G, Bishop C, Cheung L, Hawks C, Martin A, McCombie SP, Redfern AD, Davis ID, Stockler MR. PMID: 41633899 [PubMed - as supplied by publisher]
	Updated 5-year Survival Results from PURE-01, a Phase 2 Study of Neoadjuvant Pembrolizumab Followed by Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer. Eur Urol Tateo V, Basile G, Giannatempo P, de Jong JJ, Proudfoot JA, Maiorano BA, Cigliola A, Mercinelli C, Davicioni E, Moschini M, Tremolada G, Rota S, Brembilla G, Colecchia M, De Cobelli F, Montorsi F, Necchi A. PMID: 41633898 [PubMed - as supplied by publisher]
	Clinical Analysis of Primary Prostatic Diffuse Large B-Cell Lymphoma. Ann Clin Lab Sci Cui SJ, Yin H, Liu Q, Huang DP, Chen Y. PMID: 41633658 [PubMed - indexed for MEDLINE]
	Review: Differentiating Various Renal Cell Tumors with Clear Cytoplasmic Features, Old and New, Based on Their Different Renal Tubular Origins. Ann Clin Lab Sci Zhang KJ, Hafron JM, Xie C, Patel SM, Metcalf BM, Zhang PL. PMID: 41633656 [PubMed - indexed for MEDLINE]
	Beyond Total PSA: Clinical Significance of S2,3PSA% in Reducing Unnecessary Prostate Biopsies. Int J Urol Hatakeyama S, Yoneyama T, Ohyama C. PMID: 41633367 [PubMed - indexed for MEDLINE]
	Six IL-8 gene polymorphisms and the entire cancer susceptibility according to a comprehensive analysis especially in prostate cancer. Clinics (Sao Paulo) Zhang X, Sun J, Ding X. PMID: 41633311 [PubMed - as supplied by publisher]
	Happening in the Prostate Tumor Microenvironment: Ion Channels and Extrachromosomal DNA Driving Phenotypic Plasticity. Prostate Darbandi S, Urbanucci A, Hakkola S, Gujral J, Darbandi M, Eraky A, Nair S, Chakraborty G, Tewari A, Kyprianou N. PMID: 41632930 [PubMed - as supplied by publisher]
	Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the MEET-URO 33 study. Cancer Immunol Immunother Maffezzoli M, Signori A, Acunzo A, Buti S, Bosoni M, Verzoni E, Di Marco A, Lolli C, Di Napoli M, Fanelli M, Volta AD, Masini C, Roviello G, Iacovelli R, Mennitto A, Filippi R, Sorarù M, Formisano L, Guida A, Fantinel E, Messina C, Bonomi L, Scagliarini S, Nasso C, Chiellino S, Maiorano BA, Deppieri F, Cavo A, Conteduca V, Zai S, Zucali PA, Tucci M, Vignani F, La Russa F, Lombardo L, Caserta C, Paolieri F, Bertolotti F, Rescigno P, Banna GL, Fornarini G, Bimbatti D, Rebuzzi SE. PMID: 41632305 [PubMed - indexed for MEDLINE]
	Targeting HIF-2Î± in renal cell carcinoma: Expanding upon belzutifan. Cancer Rodriguez M, Qin Q, Tambar UK, Brugarolas J. PMID: 41632099 [PubMed - indexed for MEDLINE]
	A comparative evaluation of large language models for simplifying prostate cancer pathology reports: ChatGPT and Gemini. Int J Surg Zeng H, Yuan Y, Wu X, Ye Z, Yuan H, Luo S, Zhang K, Wang L, Liu H, Yang H. PMID: 41632012 [PubMed - as supplied by publisher]
	The PRIMARY Scoring System on PSMA PET for Clinically Significant Prostate Cancer Detection: A Systematic Review and Meta-Analysis. Clin Nucl Med Mourato FA, Schmitt LG, Mariussi M, Torri G, Altmayer S, Metser U, Veit-Haibach P, Brandão S, Purysko AS, Woo S, Dias AB. PMID: 41631935 [PubMed - as supplied by publisher]

Articles 1 - 20 / 175719

Page 1 of 8786



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy